Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications Health Condition 2: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 60 years or above. Diagnosed with Type 2 Diabetes Mellitus. Currently undergoing standard pharmacotherapy for diabetes management. Willing to provide informed consent and participate in the study
Exclusion criteria
Exclusion criteria: Patients with terminal illnesses. Patients with severe complications of diabetes, such as end-stage renal disease, may be excluded from participation. Patients with psychiatric illnesses or cognitive impairments. Patients with a history of stroke that significantly limits their ability to engage in the intervention or adhere to the study protocol. Uncontrolled comorbidities require immediate intensive care.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in glycemic control as measured by HbA1c levels.Timepoint: Baseline, 6 months, and 12 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in medication adherence, and Change in quality of life.Timepoint: Baseline, 6 months, and 12 months.;Change in direct medical costs, including hospital visits and medication expenses and Number and category of Drug-Related Problems (DRPs) identified and addressed.Timepoint: Baseline, 6 months, and 12 months. | — |
Countries
India
Contacts
Dept. of General Medicine, Justice K.S. Hegde Charitable Hospital, NITTE (Deemed to be University)